Clinical Trial Update: Study on Reduced Antibiotic Treatment vs Broad Spectrum Betalactam in Patients With Bacteremia by Enterobacteriaceae [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing reduced-duration antibiotic therapy to broad-spectrum beta-lactam treatment in bacteremia due to Enterobacteriaceae has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Enterobacteriaceae Infections

Snippet

Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | Conditions: Enterobacteriaceae Infections | Phase 3 | Status: COMPLETED